Reuters logo
BRIEF-Oncosec Medical Inc says has ‍initiated phase 2b registration directed trial, pisces/keynote-695
October 10, 2017 / 12:55 PM / 2 months ago

BRIEF-Oncosec Medical Inc says has ‍initiated phase 2b registration directed trial, pisces/keynote-695

Oct 10 (Reuters) - Oncosec Medical Inc

* Oncosec initiates registration directed clinical trial, keynote-695, of immunopulse® il-12 in combination with merck’s keytruda® (pembrolizumab)

* Oncosec Medical Inc - ‍initiated phase 2b registration directed trial, pisces/keynote-695 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below